Thursday, April 4, 2024 at 2:00 PM EDT            Pricing: Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

Inflammatory Bowel Disease (IBD) is a chronic, unpredictable, inflammatory disorder of the digestive tract with major clinical and economic burden. The American Gastroenterological Association Guidelines and the STRIDE-II Recommendations include long-term goals for the management of IBD, with a focus on long-term patient outcomes.  The objective of this webinar is to review IBD, treatment guidelines and professional recommendations, clinical decision making and the associated economic burden.

Learning Objectives

• Discuss the epidemiology of IBD and clinical burden of the disease that often requires multiple treatment options for patients.
• Review the AGA Guidelines and Treat to Target approach from the STRIDE-II recommendations.
• Discuss the role of targeting endoscopic remission.
• Discuss the impact of disease progression and long-term outcomes with the early use of advanced treatment options for Crohn’s Disease and ulcerative colitis.
• Clinical considerations of treatment.
• Review the future state of IBD therapy.

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

Sponsored by:

For individuals from the media/press interested in attending, please email media@amcp.org.